Why the study?
Does adherence to antihypertensive medication improve blood pressure outcomes in hypertensive patients?
Does adherence to antihypertensive medication improve blood pressure outcomes in hypertensive patients?
Adherence to antihypertensive medication and physician vigilance are associated with better blood pressure outcomes, with a significant portion of blood pressure variance attributable to physician-level effects.
Answers are grounded in this paper and cite their sources.
Adherence counseling merits emphasis in hypertension care; reinforces physician-level effects on BP control in meta-analytic data.
The authors used pooled data from 6 valsartan-related studies including 3983 adherent and 10,663 nonadherent patients to evaluate blood pressure (BP) outcomes in both groups after 90 days of treatment, applying hierarchical linear and logistic regression to identify determinants of BP outcomes. The principal findings were that: (1) BP outcomes were consistently better in adherent patients; (2) approximately a quarter of the variance in 90-day BP values was attributable to a physician class effect; (3) common and unique patient- and physician-related variables were associated with BP outcomes in both groups; (4) physician vigilance was associated with better outcomes, especially in adherent patients; and (5) adherent patients were more likely to exhibit target organ damage and associated events while being prescribed more complex medication regimens. Adherence to antihypertensive medication may be a function of prior line treatment failure, severity of illness, and sequelae, and the ensuing patient resolution to change medication behavior.
No takes yet. Share an insight, caveat, or question.
Abraham et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: